fep blue glp-1 coverage 2025 BCBS (Federal Employee Program, FEPBlue) GLP-1 Pipeline Update: November 2025

All results referenced are based on self-reported data from MEDVi patients

To turn this mechanistic insight into a targeted therapy, we developed cartilage-targeting silk fibroin nanoparticles modified with a type II collagen-binding peptide WYRGRL for localized GLP-1RAs delivery (GLP-1RAs@NPs-WYRGRL)

The GLP-1s that can be prescribed for obesity include Novo's Wegovy injection and the drug's tablet form as well as Lilly's rival pill Foundayo and its obesity shot Zepbound in the KwikPen formulation

Safety signals: FDA's significant-risk list cites serious adverse events associated with CJC-1295, including increased heart rate and systemic vasodilatory reaction